Thomas P. O’Neill

President & CEO

Thomas O'Neill Thomas P. O’Neill joined Cognivue® in April, 2018 as President and CEO. Mr. O’Neill has more than 25 years of experience leading commercial operations and a proven track record in growing revenue and EBITDA while driving operational excellence and improving customer satisfaction. Prior to joining Cognivue, Mr. O’Neill served as President, North American Commercial Operations for Qiagen, a global leader in molecular diagnostics and life sciences where he helped set the stage for long-term sustainable growth.

Prior to Qiagen, he served as the President for Hologic’s GYN, Surgical Solutions business, where he led the turnaround and significant top and bottom line growth for the Division. From 2013 to 2015, Mr. O’Neill was the President for North American Commercial Operations for Ortho Clinical Diagnostics, where he was responsible for $850 million in revenue and oversaw more than 600 professionals across all commercial functions. Under his leadership, Ortho Clinical exceeded all financial targets and restored growth to the North American business. From 2009 to 2013, Mr. O’Neill held positions of increasing responsibility at Bausch + Lomb Incorporated, most recently as Vice President and General Manager, North American Vision Care.

Prior to Bausch + Lomb, Mr. O’Neill held leadership positions at SynergEyes and Valeant Pharmaceuticals. From 1994 to 2005, he held sales and marketing positions within the Johnson and Johnson Family of Companies including Ortho-McNeil Pharmaceuticals, McNeil Consumer Healthcare and J&J/Merck. Mr. O’Neill received a B.S. in Business Administration and Marketing from the University of Akron.

Rafael O. Rivero, MD

Rafael RiveroVice President, Clinical Development and Medical Affairs

Rafael brings 17 years of global experience leading, impacting and transforming high performance teams executing across Global Health Care Systems and is highly experienced in clinical and global market development, bridging unmet medical needs and achieving gold standard of care within the Start-Ups, Biotech, Pharmaceutical, Medical Device Industries in USA, EMEA and ASPAC and LATAM.

Rafael Joined Cognivue® as Vice President of Clinical Development and Medical Affairs in May of 2018. Prior to Cognivue, Rafael served as EMEA Sr Director of Medical and Business Operations for the Cardio Renal Syndrome Biomarkers portfolio for Ortho Clinical Diagnostics and focused on NephroCheck® for Surgical and Sepsis Acute Kidney Injury. Previously, he served as Sr Clinical Scientist at Gilead Sciences for HIV/AIDS Protease and Integrase Inhibitors compounds and Sovaldi® for Hepatitis C.

From 2002 – 2006 Rafael led Medical Affairs activities for Molecular Diagnostics PhenoSense GT® with Monogram Biosciences and from 2006 – 2010 with Abbott Global R&D Virology for HIV/AIDS protease inhibitors leading both to standard of care, guidelines preferred status and expanding label and indications. From 2010 – 2012 Rafael served as North America Director of Clinical Development and Training for Stereotaxis Niobe® as first Robotic 3D enable remote magnetic navigation technology to treat and cure heart arrhythmias.

Prior to joining the Industry, Rafael dedicated his passion to the underserved triple diagnosed patients suffering from Mental Health, Substance Abuse and Infectious Diseases and specifically in Washington DC where he served as Medical Director for Andromeda Mental Health Center and later securing funding and serving as Co PI and National Director of Education and Clinical Capacity Building for the National Minority AIDS Education and Training Center, headquartered out of Howard University.

Rafael received his MD at Superior School of Medicine in Cuba in 1992 and in 1995 his USMLE Internal Medicine in Washington, DC. Rafael also holds a Master’s in Clinical Virology from Universidad del Rey Juan Carlos, Madrid, SP and various Mental Health and Infectious Disease Clinical training and certifications.

Paul EstesPaul W. Estes

Director of Operations

Beginning in 2009, Paul Estes helped conceive and develop Cognivue® technology, playing integral roles in de novo 510(k) clearance from the U.S. Food and Drug Administration and its commercialization.

Today, as Director of Operations and a member of the company’s leadership team, he collaborates on planning for technology roadmaps, new product development and expansion, business relations, sales team integration, and staffing. He also holds responsibility for intellectual property management, quality and regulatory affairs, manufacturing, software development, and customer training and support.

Paul has a B.S. degree in Education from Houghton College.

Jeff Keys

Jeff Keys

Director of Key Accounts

Jeff Keys joined Cognivue® in April 2018 as Director of Key Accounts and a member of the leadership team. With nearly 15 years in medical device executive and sales roles, he has grown revenues and built high performing teams by focusing on the customer experience.

At Cognivue, Jeff is collaborating with integrated delivery networks and hospital groups to gain market adoption for the company’s innovative system.  He is also working closely with clinical account managers on training and sales implementation to drive market penetration and growth.

Jeff previously served as area Sales Manager for Invuity, a leader in surgical photonics, and with Intuitive Surgical, where he was instrumental in growing the adoption of robotic surgery. He also held roles with Medical Action Industries, leading an eight-state sales team. Jeff holds a B.S. in Business Administration from Nazareth College.



Cognivue has been a great addition!!!! Far better than the MMSE...I say it is a cognitive CBC or EKG and patients are educated in a way we couldn't do before...and so am I!

Dr. C. Stringer, CNY Internists PC


Sign-up to schedule a Cognivue demo!

Click Here